论文部分内容阅读
卫生部药品审评委员会西药分委员会于六月十五日至二十日在京召开了新药审评会,对七个申请生产的一类新药进行了技术审评。这七个新药是:军事医学科学院研制的镇痛药盐酸双氢埃托菲及其片剂和注射液;治疗疟疾的药物本芴醇及其胶囊;四川抗菌素研究所、无锡第一制药厂、四川长征制药厂联合研制的抗结核药环戊哌嗪利福霉素及其胶囊;上海五洲
The Western Medicine Subcommittee of the Drug Evaluation Committee of the Ministry of Health convened a review meeting for new drugs in Beijing from June 15 to June 20 to conduct a technical review of the seven new drugs that have been applied for production. The seven new drugs are: analgesics developed by the Military Academy of Medical Sciences dihydroepithelium hydrochloride tablet and its injection; treatment of malaria drug lumefrin alcohol and its capsules; Sichuan Institute of antibiotics, Wuxi First Pharmaceutical Factory, Sichuan Changzheng Pharmaceutical Factory jointly developed the anti-TB drug cyclopentyl piperazine rifamycin and its capsules; Shanghai Wuzhou